• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Bioengineering Cardiac Tissue Constructs With Adult Rat Cardiomyocytes.用成年大鼠心肌细胞构建生物工程心脏组织。
ASAIO J. 2018 Sep/Oct;64(5):e105-e114. doi: 10.1097/MAT.0000000000000765.
2
Optimizing a spontaneously contracting heart tissue patch with rat neonatal cardiac cells on fibrin gel.在纤维蛋白凝胶上用鼠胚心肌细胞优化自发收缩的心肌组织片。
J Tissue Eng Regen Med. 2017 Jan;11(1):153-163. doi: 10.1002/term.1895. Epub 2014 Apr 28.
3
Force characteristics of in vivo tissue-engineered myocardial constructs using varying cell seeding densities.使用不同细胞接种密度的体内组织工程心肌构建体的力学特性
Artif Organs. 2008 Sep;32(9):684-91. doi: 10.1111/j.1525-1594.2008.00591.x. Epub 2008 Jul 30.
4
16-Channel Flexible System to Measure Electrophysiological Properties of Bioengineered Hearts.用于测量生物工程心脏电生理特性的16通道柔性系统。
Cardiovasc Eng Technol. 2018 Mar;9(1):94-104. doi: 10.1007/s13239-017-0336-8. Epub 2017 Nov 17.
5
Contractile three-dimensional bioengineered heart muscle for myocardial regeneration.用于心肌再生的收缩性三维生物工程心肌。
J Biomed Mater Res A. 2007 Mar 1;80(3):719-31. doi: 10.1002/jbm.a.31090.
6
Single-Cell Transcriptomics of Engineered Cardiac Tissues From Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals Abnormal Developmental Trajectory and Intrinsic Contractile Defects in Hypoplastic Right Heart Syndrome.从患者特异性诱导多能干细胞衍生的心肌细胞构建的工程化心脏组织的单细胞转录组学揭示了右心发育不全综合征中的异常发育轨迹和内在收缩缺陷。
J Am Heart Assoc. 2020 Oct 20;9(20):e016528. doi: 10.1161/JAHA.120.016528. Epub 2020 Oct 16.
7
Cardiac tissue engineering in an in vivo vascularized chamber.体内血管化腔室中的心脏组织工程
Circulation. 2007 Jan 23;115(3):353-60. doi: 10.1161/CIRCULATIONAHA.106.657379. Epub 2007 Jan 2.
8
I-Wire Heart-on-a-Chip I: Three-dimensional cardiac tissue constructs for physiology and pharmacology.I型线控芯片心脏I:用于生理学和药理学研究的三维心脏组织构建体
Acta Biomater. 2017 Jan 15;48:68-78. doi: 10.1016/j.actbio.2016.11.009. Epub 2016 Nov 4.
9
Development of a Cyclic Strain Bioreactor for Mechanical Enhancement and Assessment of Bioengineered Myocardial Constructs.用于机械增强和评估生物工程心肌构建体的循环应变生物反应器的开发。
Cardiovasc Eng Technol. 2015 Dec;6(4):533-45. doi: 10.1007/s13239-015-0236-8. Epub 2015 Jul 24.
10
Design and fabrication of heart muscle using scaffold-based tissue engineering.利用基于支架的组织工程技术设计与制造心肌。
J Biomed Mater Res A. 2008 Jul;86(1):195-208. doi: 10.1002/jbm.a.31642.

引用本文的文献

1
Insights into the molecular mechanism of pulmonary vein stenosis in pediatric patients with congenital heart disease.先天性心脏病患儿肺静脉狭窄分子机制的研究进展
JTCVS Open. 2025 Apr 24;26:166-181. doi: 10.1016/j.xjon.2025.04.012. eCollection 2025 Aug.
2
Application of human cardiac organoids in cardiovascular disease research.人类心脏类器官在心血管疾病研究中的应用。
Front Cell Dev Biol. 2025 Mar 31;13:1564889. doi: 10.3389/fcell.2025.1564889. eCollection 2025.
3
Development of Novel 3D Spheroids for Discrete Subaortic Stenosis.用于离散性主动脉瓣下狭窄的新型3D球体的研发。
Cardiovasc Eng Technol. 2024 Dec;15(6):704-715. doi: 10.1007/s13239-024-00746-x. Epub 2024 Nov 4.
4
An Integrated Optogenetic and Bioelectronic Platform for Regulating Cardiomyocyte Function.一种用于调节心肌细胞功能的光遗传学和生物电子学综合平台。
Adv Sci (Weinh). 2024 Sep;11(36):e2402236. doi: 10.1002/advs.202402236. Epub 2024 Jul 25.
5
An Integrated Optogenetic and Bioelectronic Platform for Regulating Cardiomyocyte Function.用于调节心肌细胞功能的集成光遗传学和生物电子平台。
bioRxiv. 2023 Dec 15:2023.12.15.571704. doi: 10.1101/2023.12.15.571704.
6
Recent advances in biological pumps as a building block for bioartificial hearts.作为生物人工心脏组成部分的生物泵的最新进展。
Front Bioeng Biotechnol. 2023 Jan 20;11:1061622. doi: 10.3389/fbioe.2023.1061622. eCollection 2023.
7
Research Progress of Three-Dimensional Bioprinting Artificial Cardiac Tissue.三维生物打印人工心脏组织的研究进展。
Tissue Eng Regen Med. 2023 Feb;20(1):1-9. doi: 10.1007/s13770-022-00495-9. Epub 2022 Nov 19.
8
Current State of the Art in Ventricle Tissue Engineering.心室组织工程的当前技术水平
Front Cardiovasc Med. 2020 Nov 3;7:591581. doi: 10.3389/fcvm.2020.591581. eCollection 2020.

本文引用的文献

1
Dedifferentiation, Proliferation, and Redifferentiation of Adult Mammalian Cardiomyocytes After Ischemic Injury.成年哺乳动物心肌细胞在缺血性损伤后的去分化、增殖和再分化
Circulation. 2017 Aug 29;136(9):834-848. doi: 10.1161/CIRCULATIONAHA.116.024307. Epub 2017 Jun 22.
2
Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells.从非病毒重编程的人羊水干细胞中分化出自发性收缩的心肌细胞。
PLoS One. 2017 May 17;12(5):e0177824. doi: 10.1371/journal.pone.0177824. eCollection 2017.
3
Engineering Cardiac Muscle Tissue: A Maturating Field of Research.工程化心肌组织:一个不断成熟的研究领域。
Circ Res. 2017 Apr 28;120(9):1487-1500. doi: 10.1161/CIRCRESAHA.117.310738.
4
Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening.用于心脏药物安全性筛选的人类工程心脏组织自动收缩分析
J Vis Exp. 2017 Apr 15(122):55461. doi: 10.3791/55461.
5
Engineering a functional three-dimensional human cardiac tissue model for drug toxicity screening.构建用于药物毒性筛选的功能性三维人体心脏组织模型。
Biofabrication. 2017 May 11;9(2):025011. doi: 10.1088/1758-5090/aa6c3a.
6
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.《2017年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25.
7
Triiodo-L-Thyronine Promotes the Maturation of Cardiomyocytes Derived From Rat Bone Marrow Mesenchymal Stem Cells.三碘-L-甲状腺原氨酸促进大鼠骨髓间充质干细胞来源的心肌细胞成熟。
J Cardiovasc Pharmacol. 2016 May;67(5):388-93. doi: 10.1097/FJC.0000000000000363.
8
Gata4, Tbx5 and Baf60c induce differentiation of adipose tissue-derived mesenchymal stem cells into beating cardiomyocytes.Gata4、Tbx5和Baf60c诱导脂肪组织来源的间充质干细胞分化为跳动的心肌细胞。
Int J Biochem Cell Biol. 2015 Sep;66:30-6. doi: 10.1016/j.biocel.2015.06.008. Epub 2015 Jun 10.
9
Establishing the Framework for Fabrication of a Bioartificial Heart.建立生物人工心脏制造的框架。
ASAIO J. 2015 Jul-Aug;61(4):429-36. doi: 10.1097/MAT.0000000000000233.
10
Isolation and functional characterization of human ventricular cardiomyocytes from fresh surgical samples.从新鲜手术样本中分离和鉴定人类心室心肌细胞及其功能特性
J Vis Exp. 2014 Apr 21(86):51116. doi: 10.3791/51116.

用成年大鼠心肌细胞构建生物工程心脏组织。

Bioengineering Cardiac Tissue Constructs With Adult Rat Cardiomyocytes.

机构信息

From the Department of Bioengineering, University of Colorado Denver/Anschutz Medical Campus, Aurora, Colorado.

Department of Biomedical Engineering, University of Houston, Houston, Texas.

出版信息

ASAIO J. 2018 Sep/Oct;64(5):e105-e114. doi: 10.1097/MAT.0000000000000765.

DOI:10.1097/MAT.0000000000000765
PMID:29538014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6108895/
Abstract

Bioengineering cardiac tissue constructs with adult cardiomyocytes may help treat adult heart defects and injury. In this study, we fabricated cardiac tissue constructs by seeding adult rat cardiomyocytes on a fibrin gel matrix and analyzed the electromechanical properties of the formed cardiac tissue constructs. Adult rat cardiomyocytes were isolated with a collagenase type II buffer using an optimized Langendorff perfusion system. Cardiac tissue constructs were fabricated using either indirect plating with cardiomyocytes that were cultured for 1 week and dedifferentiated or with freshly isolated cardiomyocytes. The current protocol generated (3.1 ± 0.5) × 10 (n = 5 hearts) fresh cardiomyocytes from a single heart. Tissue constructs obtained by both types of plating contracted up to 30 days, and electrogram (ECG) signals and contractile twitch forces were detected. The constructs bioengineered by indirect plating of dedifferentiated cardiomyocytes produced an ECG R wave amplitude of 15.1 ± 5.2 µV (n = 7 constructs), a twitch force of 70-110 µN, and a spontaneous contraction rate of about 390 bpm. The constructs bioengineered by direct plating of fresh cardiomyocytes generated an ECG R wave amplitude of 6.3 ± 2.5 µV (n = 8 constructs), a twitch force of 40-60 µN, and a spontaneous contraction rate of about 230 bpm. This study successfully bioengineered three-dimensional cardiac tissue constructs using primary adult cardiomyocytes.

摘要

用成体心肌细胞构建生物工程心脏组织可能有助于治疗成人心脏缺陷和损伤。在这项研究中,我们通过将成年大鼠心肌细胞接种在纤维蛋白凝胶基质上来构建心脏组织构建体,并分析了形成的心脏组织构建体的机电特性。使用优化的 Langendorff 灌注系统,用胶原酶 II 缓冲液分离成年大鼠心肌细胞。通过间接接种培养 1 周并去分化的心肌细胞或新鲜分离的心肌细胞来构建心脏组织构建体。该方案从单个心脏中产生了(3.1 ± 0.5)×10(n = 5 个心脏)个新鲜心肌细胞。两种接种方式获得的组织构建体均可收缩长达 30 天,并可检测到心电图(ECG)信号和收缩抽搐力。通过去分化心肌细胞间接接种生物工程化的构建体产生的 ECG R 波幅度为 15.1 ± 5.2 µV(n = 7 个构建体),抽搐力为 70-110 µN,自发收缩率约为 390 bpm。通过直接接种新鲜心肌细胞生物工程化的构建体产生的 ECG R 波幅度为 6.3 ± 2.5 µV(n = 8 个构建体),抽搐力为 40-60 µN,自发收缩率约为 230 bpm。本研究成功地使用原代成体心肌细胞构建了三维心脏组织构建体。